ONCO
Onconetix, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.02
+38.02%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.43x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 0.58x
Liquidity & coverage
- Current ratio
- 2.21x
- Quick ratio
- 2.14x
- Cash ratio
- 2.02x
- Interest coverage
- -26.28x
- EBITDA / interest
- -31.75x
- Working capital
- $3.6M
Cash & dividend
- FCF / debt
- -55.09x
- Cash flow / debt
- -55.09x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026